Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
Brookman-May, Sabine, May, Matthias, Gilfrich, Christian, Ferdinand Wieland, Wolf and Burger, Maximilian (2010) Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma? Expert Review of Anticancer Therapy 10 (6), pp. 813-823.Date of publication of this fulltext: 19 Dec 2024 11:36
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Expert Review of Anticancer Therapy | ||||
| Publisher: | EXPERT REVIEWS | ||||
|---|---|---|---|---|---|
| Place of Publication: | LONDON | ||||
| Volume: | 10 | ||||
| Number of Issue or Book Chapter: | 6 | ||||
| Page Range: | pp. 813-823 | ||||
| Date | 2010 | ||||
| Institutions | Medicine > Lehrstuhl für Urologie | ||||
| Identification Number |
| ||||
| Keywords | PHASE-III TRIAL; CHEMOIMMUNOTHERAPY-GROUP DGCIN; CARBONIC-ANHYDRASE-IX; DISEASE-FREE SURVIVAL; REGULATORY T-CELLS; RADICAL NEPHRECTOMY; RANDOMIZED-TRIAL; INTERFERON-ALPHA; PROGNOSTIC MODEL; DENDRITIC CELLS; adjuvant therapy; cytokine immunotherapy; renal cell carcinoma; risk stratification; surgical resection; targeted drug; vaccination immunotherapy | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 66053 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric